• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EBI, LLC. SPINALPAK STIMULATOR, BIOMET; STIMULATOR, BONE GROWTH, NON-INVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EBI, LLC. SPINALPAK STIMULATOR, BIOMET; STIMULATOR, BONE GROWTH, NON-INVASIVE Back to Search Results
Model Number N/A
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Thrombus (2101)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Zimmer biomet complaint: (b)(4).Date of event: the event occurred sometime in (b)(6) 2019.The device has not been returned for analysis.However, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.
 
Event or Problem Description
It was reported that the patient developed blood clots from using spinalpak.Patient stated to have used unit for 3 days and then was admitted to hospital for blood clots.No additional patient consequences were reported.
 
Additional Manufacturer Narrative
This follow up report is being submitted to relay additional information.The device was not returned to zimmer biomet for evaluation.The reported event was unable to be confirmed due to limited information received from the customer.The device history record (dhr) was reviewed and no discrepancies were found.The root cause was unable to be determined as the necessary information to adequately investigate the reported event was not provided.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.The following sections were updated: b4: date of this report added.G1-2: contact name/address added.G4: date received by manufacturer.G7: type of report.H2: follow up type.H3: device evaluated by manufacturer updated to no.H4: device manufacturer date added.H6: device code updated to 3190: insufficient information.H6: method code updated to 4114: device not returned.H6: method code updated to 3331: analysis of production records.H6: results code updated to 3221: no findings available.H6: conclusions code updated to 4315: cause not established.H10: additional narratives/data.H3 other text : the device has not been returned.
 
Event or Problem Description
It was reported that the patient developed blood clots from using spinalpak.Patient stated to have used unit for 3 days and then was admitted to hospital for blood clots.No additional patient consequences were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPINALPAK STIMULATOR, BIOMET
Common Device Name
STIMULATOR, BONE GROWTH, NON-INVASIVE
Manufacturer (Section D)
EBI, LLC.
399 jefferson road
parsippany NJ 07054
MDR Report Key8807317
Report Number0002242816-2019-00019
Device Sequence Number13538790
Product Code LOF
UDI-Device Identifier00812301020225
UDI-Public00812301020225
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P850022
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 01/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberN/A
Device Catalogue Number1067717
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 07/09/2019
Supplement Date Received by Manufacturer01/03/2020
Initial Report FDA Received Date07/19/2019
Supplement Report FDA Received Date01/06/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
N/A
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
-
-